enVVeno Medical Corp
Company Profile
Business description
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
Contact
70 Doppler
IrvineCA92618
USAT: +1 949 261-2900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
37
Stocks News & Analysis
stocks
Are small caps finally back?
stocks
Chart of the Week: Modest earnings growth at odds with overvalued bank shares
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,295.80 | 17.60 | 0.19% |
CAC 40 | 8,206.87 | 51.99 | -0.63% |
DAX 40 | 24,151.13 | 178.90 | -0.74% |
Dow JONES (US) | 46,590.41 | 334.33 | -0.71% |
FTSE 100 | 9,515.00 | 88.01 | 0.93% |
HKSE | 25,781.77 | 245.78 | -0.94% |
NASDAQ | 22,740.40 | 213.27 | -0.93% |
Nikkei 225 | 49,307.79 | 8.27 | -0.02% |
NZX 50 Index | 13,316.26 | 9.82 | 0.07% |
S&P 500 | 6,699.40 | 35.95 | -0.53% |
S&P/ASX 200 | 9,004.50 | 18.30 | 0.20% |
SSE Composite Index | 3,913.76 | 2.57 | -0.07% |